Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marsh

Showing results (501-510 of 654) with videos related to

Pageof 66
Sort By:
Cancer Journal (Sudbury, Mass.)|November 18, 2000
A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusionB Burtness, M Belker, M Stoltz, et al.
Journal of Medicinal Chemistry|July 11, 2009
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationshipsChen Zhao, Minghua Sun, Youssef L Bennani, et al.
Drug and Alcohol Dependence|February 24, 2015
Testosterone suppression in opioid users: a systematic review and meta-analysisMonica Bawor, Herman Bami, Brittany B Dennis, et al.
Hospital Pediatrics|July 5, 2018
Clinical Characteristics and Health Outcomes of Neonates Reporting to the Emergency Department With HypothermiaJulie K Wood, Elizabeth E Halvorson, Jeanna R Auriemma, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|February 8, 2024
An Exploratory Analysis of Physical Examination Subtypes in Pediatric Athletes With ConcussionJacob I McPherson, Amanda C Marsh, Adam Cunningham, et al.
Journal of Cardiovascular Pharmacology|September 23, 2009
Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogsJames S Polakowski, Andrew J King, Thomas J Campbell, et al.
Glycobiology|June 11, 2004
Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technologyLawrence J Thomas, Krishnasamy Panneerselvam, David T Beattie, et al.
Drug and Alcohol Dependence|May 19, 2017
Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorderEugenia Oviedo-Joekes, Suzanne Brissette, Scott MacDonald, et al.
Trials|October 23, 2015
Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteriaBrittany B Dennis, Pavel S Roshanov, Leen Naji, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 29, 2025
Rat and dog quad-culture liver chip models: Characterization and use to interrogate a potential flavin-containing monooxygenase-mediated, species-specific toxicity of a histamine receptor antagonistDavid Kukla, Tatiana A Sharapova, Rita Ciurlionis, et al.
Pageof 66

Showing results (501-510 of 654) with videos related to

Sort By:
Pageof 66
Cancer Journal (Sudbury, Mass.)|November 18, 2000
A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusionB Burtness, M Belker, M Stoltz, et al.
Journal of Medicinal Chemistry|July 11, 2009
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationshipsChen Zhao, Minghua Sun, Youssef L Bennani, et al.
Drug and Alcohol Dependence|February 24, 2015
Testosterone suppression in opioid users: a systematic review and meta-analysisMonica Bawor, Herman Bami, Brittany B Dennis, et al.
Hospital Pediatrics|July 5, 2018
Clinical Characteristics and Health Outcomes of Neonates Reporting to the Emergency Department With HypothermiaJulie K Wood, Elizabeth E Halvorson, Jeanna R Auriemma, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|February 8, 2024
An Exploratory Analysis of Physical Examination Subtypes in Pediatric Athletes With ConcussionJacob I McPherson, Amanda C Marsh, Adam Cunningham, et al.
Journal of Cardiovascular Pharmacology|September 23, 2009
Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogsJames S Polakowski, Andrew J King, Thomas J Campbell, et al.
Glycobiology|June 11, 2004
Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technologyLawrence J Thomas, Krishnasamy Panneerselvam, David T Beattie, et al.
Drug and Alcohol Dependence|May 19, 2017
Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorderEugenia Oviedo-Joekes, Suzanne Brissette, Scott MacDonald, et al.
Trials|October 23, 2015
Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteriaBrittany B Dennis, Pavel S Roshanov, Leen Naji, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 29, 2025
Rat and dog quad-culture liver chip models: Characterization and use to interrogate a potential flavin-containing monooxygenase-mediated, species-specific toxicity of a histamine receptor antagonistDavid Kukla, Tatiana A Sharapova, Rita Ciurlionis, et al.
Pageof 66